NovoCure Ltd
NVCR
Market Cap$1.53B
Close$
$2.08
85.3% downside
Current Fair Value
85.3% downsideOvervalued by 85.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.53 Billion |
|---|---|
| Enterprise Value | $1.19 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.95 |
| Beta | 1.74 |
| Outstanding Shares | 107,606,309 |
| Avg 30 Day Volume | 1,096,294 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.38 |
|---|---|
| PEG | -28.14 |
| Price to Sales | 3.55 |
| Price to Book Ratio | 4.73 |
| Enterprise Value to Revenue | 2.33 |
| Enterprise Value to EBIT | -5.09 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | 1.57 |
Revenue Sources
No data
ESG Score
No data
About NovoCure Ltd
CEO: Asaf Danziger